Skip to content

Study of efficacy evaluation and influence factors of Chinese medical treatment for patients with neocrown pneumonia based on real world

Study of efficacy evaluation and influence factors of Chinese medical treatment for patients with neocrown pneumonia based on real world

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2100005222
Enrollment
Unknown
Registered
2021-08-17
Start date
2021-08-15
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel coronavirus pneumonia (COVID-19)

Interventions

Sponsors

The First Affiliated Hospital of He'nan University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Meet the definition of confirmed patients and asymptomatic infections with delta variant new coronary pneumonia; 2. Aged 18-80 years; 3. The clinical classification of confirmed cases is light, common, severe, and critical;

Exclusion criteria

Exclusion criteria: 1. Not using syndrome differentiation therapy or syndrome differentiation therapy for less than 3 days; 2. Dementia, various mentally ill patients; 3. Pregnant and lactating patients; 4. Those who are participating in clinical trials of other drugs and are known to be allergic to therapeutic drugs.

Design outcomes

Primary

MeasureTime frame
Nucleic acid conversion time and rate of conversion;

Secondary

MeasureTime frame
Depression Self-Rating Scale (SDS) scores;All cause rehospitalization rate;Prognosis;Incidence of complications;Pneumonia patient-reported outcome scale (CAP-PRO) score;Chest imaging;Clinical symptomes;Anxiety Self-Assessment Scale (SAS) scores;Post traumatic stress disorder checklist score;

Countries

China

Contacts

Public ContactLi Suyun
lisuyun2000@126.com+86 371 66248624

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026